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Abstract
Background: Gonadectomy is one of the most common procedures performed on dogs in the United States.
Neutering has been shown to reduce the risk for some diseases although recent reports suggest increased
prevalence for structural disorders and some neoplasias. The relation between neuter status and autoimmune
diseases has not been explored. This study evaluated the prevalence and risk of atopic dermatitis (ATOP),
autoimmune hemolytic anemia (AIHA), canine myasthenia gravis (CMG), colitis (COL), hypoadrenocorticism (ADD),
hypothyroidism (HYPO), immune-mediated polyarthritis (IMPA), immune-mediated thrombocytopenia (ITP),
inflammatory bowel disease (IBD), lupus erythematosus (LUP), and pemphigus complex (PEMC), for intact females,
intact males, neutered females, and neutered males. Pyometra (PYO) was evaluated as a control condition.
Results: Patient records (90,090) from the William R. Pritchard Veterinary Medical Teaching Hospital at the University
of California, Davis from 1995 to 2010 were analyzed in order to determine the risk of immune-mediated disease
relative to neuter status in dogs. Neutered dogs had a significantly greater risk of ATOP, AIHA, ADD, HYPO, ITP, and
IBD than intact dogs with neutered females being at greater risk than neutered males for all but AIHA and ADD.
Neutered females, but not males, had a significantly greater risk of LUP than intact females. Pyometra was a greater
risk for intact females.
Conclusions: The data underscore the importance of sex steroids on immune function emphasizing a role of these
hormones on tissue self-recognition. Neutering is critically important for population control, reduction of reproductive
disorders, and offers convenience for owners. Despite these advantages, the analyses of the present study suggest that
neutering is associated with increased risk for certain autoimmune disorders and underscore the need for owners to
consult with their veterinary practitioner prior to neutering to evaluate possible benefits and risks associated with such
a procedure.
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Background
Gonadectomy, commonly referred to as spay or neuter
or castration, consists of the removal of reproductive
organs and is commonly employed for pet population
control and to confer health and behavior benefits [1–7].
Controlling the canine population has become an import-
ant issue for the United States, with the American Veterin-
ary Medical Association identifying it as a societal welfare
concern [3]. In the U.S., dogs are generally neutered after
the age of 6 months and 64% of dogs are neutered [3]. In
contrast to the U.S., some countries view neutering as an
unnecessary or undesirable procedure. Sweden has a 98.9%
intact rate for dogs [8] and other regions in Europe and
South America also have high frequency of intact dogs
[9–11]. Despite being one of the most common proce-
dures performed by veterinarians in the United States,
recent reports outline detrimental health impacts of
neutering in the dog [1, 2, 12–16].
Neutering dogs has been shown to reduce the risk of
certain reproductive problems such as mammary cancer
[2], pyometra [1], or testicular cancer [2]. Recent pub-
lications have described health impairments caused by
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neutering with the majority of these studies focused
on cancer and orthopedic conditions [1, 2, 13–16],
with only a few studies assessing metabolic impacts.
For example, neutered dogs have a decreased energy
requirement and may become obese [12], and young
dogs with immature thermoregulation, hepatic, renal, and
protein binding function may be sensitive to the neutering
surgical procedure [1, 13]. Skeletal development is regu-
lated by gonadal hormones signaling closure of the physes
of long bones; neutering prior to closure can result in
elongated long bones [17] potentially contributing to joint
disorders being more prevalent in dogs neutered before
puberty [1, 2, 15, 16]. An increased prevalence of various
neoplasms has also been correlated with gonadal function,
as evidenced by the presence of gonadal hormone recep-
tors in some neoplastic tissues [1, 14]. A threefold increase
in transitional cell carcinoma of the urinary bladder for
both sexes when neutered has been reported [2]. More-
over, hemangiosarcoma, osteosarcoma, and lymphosar-
coma also show an increase in prevalence in neutered
dogs compared to intact dogs [1, 2, 14–16]. Neutering is
also associated with increased life expectancy, however
compared to intact dogs, neutered dogs have an increased
risk of death more from cancer and immune-mediated
diseases and less from infections, trauma, and vascular
disease [18].
One area that has not been explored in great depth is
the impact of neutering on the immune system and its
ability to combat disease. An association with neuter sta-
tus has been reported for myasthenia gravis [19, 20] and
immune-mediated hemolytic anemia [21] but little ex-
ploration for other immune mediated conditions. The
reproductive system and the immune system are highly
interdependent. The present study sought to evaluate if
there was an association between neuter status and dis-
eases thought to be modulated by the immune system.
Immune tissues, such as thymus, thymocytes, lymph nodes
and spleen, display gonadal steroid receptors [22, 23].
Ablation of the thymus, the tissue in which T lymphocytes
mature, disrupts gonadal development, reduces sex steroid
production, and interrupts reproductive cycles [22] whereas
male mice neutered at an early age show delayed thymic in-
volution, thymic hyperplasia and depressed humoral and
cell-mediated immune function when given testosterone
[24]. An ancillary question was whether males differed from
females in the effects of neutering because it is known that
there are distinct sex differences in immune components
with female dogs displaying stronger cell-mediated and
humoral responses, higher immunoglobulin levels [25, 26],
greater percentages of CD8 T cells [27], and a greater
susceptibility to autoimmune disorders when compared
to males [24, 26, 27]. Other studies in mice demonstrate
that females produce more immunoglobulins than males,
mount a more vigorous immune cascade in response to
infection or immunization, and generate more autoanti-
bodies making females more susceptible to autoimmune
disorders [23, 24, 28]. The role of estrogens in modulating
immune function is particularly apparent within the fe-
male reproductive tract in which protection from infec-
tious disease must be balanced with the acceptance of
conceptus implantation [29]. The approach taken for the
present study was a retrospective analysis of dogs seen at a
veterinary teaching hospital for a range of autoimmune
conditions affecting multiple body systems.
Methods
The dogs under study were those seen by the Veterinary
Medical Teaching Hospital at the University of California,
Davis from January 1, 1995 through January 1, 2010. Med-
ical records of 90,090 individual dogs, inclusive of all AKC
breeds as well as mixed breeds, were examined. The
process of examining the medical records was described
in [30]. Briefly, patients were classified as affected by a dis-
ease only if a confirmed diagnosis based on symptoms and
test results was indicated in the records. If a disease was
only regarded as a possible suspect, but not confirmed,
the patient was not designated as affected by the disease.
All data fields within the medical records were analyzed
by searching for key words and phrases of the diseases
evaluated. Spayed female dogs and castrated male dogs are
collectively referred to as neutered. Sex status was also
recorded for each dog as either intact or neutered. The
date of initial disease diagnosis was determined from
the records. To ensure reliability, age of neuter was
only determined for dogs neutered at the teaching hos-
pital. Dogs that were neutered within 150 days of that
initial diagnosis were classified as intact at the time of
diagnosis.
The immune medical conditions selected were those
having a prevalence in excess of 0.1% in the dog popula-
tion studied, recognized as having an underlying immune
causality, and impacting multiple organ systems: atopic
dermatitis (ATOP) autoimmune hemolytic anemia
(AIHA), canine myasthenia gravis (CMG) colitis (COL),
hypoadrenocorticism (ADD), hypothyroidism (HYPO),
immune-mediated polyarthritis (IMPA), immune-mediated
thrombocytopenia (ITP), inflammatory bowel disease
(IBD), lupus erythematosus (LUP), and pemphigus com-
plex (PEMC) [31–37]. Lupus erythematosus included
diagnoses of both systemic lupus erythematosus (SLE) and
discoid lupus erythematosus (DLE) based upon the view
that DLE is a localized presentation of SLE [32]. Pyometra
(PYO) was used as a positive control; pyometras recorded
for neutered females were stump pyometras.
Binary data were used to determine prevalence of dis-
ease for the overall population and categories differenti-
ated by parameters of sex and age at neuter. Prevalence
was calculated by dividing the total number of dogs with
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disease within that category by the total number of dogs
in that category.
Accordingly, for a given disease, the information avail-
able is simply a set of counts of the number of cases and
controls categorized into one of four sex classes (F = intact
females, NF = neutered females, M = intact males and
NM = neutered males). Evaluation of the differences in
the probability of disease by sex class was straightfor-
ward, taking advantage of the binomial density. That is,
for a given disease and a given sex class i (i = F, NF, M,
NM), ncases i ~ Binomial(ncases i + ncontrols i , pi) where
ncases i was the number of observed cases in sex group
i, ncontrols i was the number of unaffected dogs in sex
group i and pi was the probability of disease in sex
group i. We estimated pi for each disease along with as-
sociated values of relative risk (RR) and the odds ratio
(OR) across the sex groups [38].
Specifically, we evaluated the relative risk for females
as RRF = pNF/pF and that for males as RRM = pNM/pM.
In addition, we defined the odds ratios for females
and males as ORF = [pNF/(1-pNF)]/[pF/(1-pF)] and
ORM = [pNM/(1- pNM)]/[pM/(1-pM)], respectively. Esti-
mation of these measures of differences in disease
prevalence across the sex classes, along with their
associated confidence intervals, can be accomplished
by several methods [38] and we opted to use a hierarch-
ical Bayesian framework facilitated through the public-
domain software Stan [39] which can be accessed through
the public-domain language R [40]. Both the OR and the
RR are presented. Though different in their interpretation,
and more importantly in their calculation, these two statis-
tics of disease risk are expected to be nearly identical when
a disease is of low prevalence. Slight variations between
the two values may exist for conditions having higher
prevalence with the OR expected to inflate the perceived
risk [41].
A hierarchical model was used because many of the
diseases to be evaluated are uncommon. Accordingly, es-
timating pi, and perhaps more importantly the standard
error of p, in those cells was expected to be quite impre-
cise. Using a hierarchical model allows imposition of
structure on the estimates of pi, thereby providing for
more reasonable and stable estimates of pi and the cred-
ible interval around pi (and thus the RR and OR) [42].
Estimation of pi was accomplished through the log-odds,
i.e., log(pi /(1- pi)) = sexi (i = F, NF, M, NM) where sexi
was the sex group effect, which, in our hierarchical
Bayesian model had a prior density of sexi ~ N(0, σ
2).
The next step in this hierarchical model, intending to
address the challenge of evaluating uncommon disor-
ders, we considered the weakly informative prior of a
half-Cauchy for σ [43], that is σ ~ Cauchy(0,25). In fitting
of this hierarchical model, the MCMC (Monte Carlo
Markov Chain) sampling process was run in 4 chains,
where each chain was based upon 20,000 total samples,
and the first 5000 were removed as part of the warm-up
process, subsequently thinned to every 20-th sample,
resulting in a MCMC sample of 3000 values [39]. Con-
vergence to the posterior density was evaluated by the
Gelman-Rubin test statistic, where values less than 1.05
would indicate that the MCMC sampling process was
adequate to the data evaluated [44].
Results
The population demographics are presented in Tables 1
and 2. Neutered dogs made up 75.93% of the dogs evalu-
ated. The overall proportion of males and females in the
population under study with these immune conditions
was 5.2 and 5.5%, respectively. The proportion of dogs
with these conditions decreased over time with an aggre-
gate prevalence of 7.55% in 1995 and 5.53% in the final
year evaluated. There were 6281 dogs neutered at the
teaching hospital with an average age (± standard error)
at neuter of 32.36 ± 0.73 and 28.61 ± 0.55 months for
males and females, respectively. The median age of neuter
(± standard error) was 13.40 ± 0.91 and 13.08 ± 0.69 months
for males and females, respectively. Average age of diagno-
sis for each condition is presented in Fig. 1. For the cases in
which age at neuter could be assessed, there were no dif-
ferences in age of gonadectomy as a function of disease
(p > 0.1). The data were not extensive enough to assess
the impact of early or late neutering on condition ex-
pression. In general, the diagnosis of disease for intact
dogs occurred at younger ages than neutered dogs.
Diagnosis of these diseases for neutered dogs occurred
more than 20 months post-gonadectomy.
The predicted probability of disease prevalence and
the 95% confidence interval (CI) for each condition are
depicted in Fig. 2. Overall, predicted probability for dis-
ease prevalence was equivalent between intact males and
intact females with the exception of atopic dermatitis
which was less prevalent in females than males. Preva-
lence of CMG, COL, IMPA, LUP, and PEMC was statis-
tically equivalent across all four sex categories.
Table 3 lists the ORs and RRs for each condition. In
general, the OR and RR for each condition were nearly
identical. Neutering increased prevalence and risk of ex-
pressing the disease over that observed for the intact
dog for some of the conditions assessed. Specifically, being
neutered increased the risk for both males and females for
Table 1 Profile of dog population evaluated
Sex Number of dogs % of total
Intact Female 9133 10.14
Neutered Female 36574 40.60
Intact Male 12555 13.94
Neutered Male 31828 35.33
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Table 2 Disease distribution by sex class
Disease Intact females Neutered females Intact males Neutered males Percent in study population
Atopic Dermatitis (ATOP) 83 745 169 641 1.82
Autoimmune Hemolytic Anemia (AIHA) 38 256 38 176 0.56
Canine Myasthenia Gravis (CMG) 11 49 6 38 0.12
Colitis (COL) 61 267 109 256 0.77
Hypoadrenocorticism (ADD) 25 147 20 113 0.34
Hypothyroidism (HYPO) 62 750 210 678 1.89
Immune-Mediated Polyarthritis (IMPA) 24 170 56 141 0.43
Immune-Mediated Thrombocytopenia (ITP) 21 262 29 151 0.51
Inflammatory Bowel Disease (IBD) 20 189 46 167 0.47
Lupus Erythematosus (LUP) 6 74 30 47 0.17
Pemphigus Complex (PEMC) 13 71 11 55 0.17
Pyometra (PYO) 176 27 NA NA 0.44
Fig. 1 Age at disease diagnosis (mean and standard error of the mean) relative to sex category for females (a) and males (b). The solid horizontal
line indicates the median age at neuter
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Fig. 2 Caterpillar plot of the predicted probability that a dog would have each of the ten immune conditions based on neuter category
parameters (data presented as mean probability ± 95% confidence interval)
Table 3 Odds ratios (OR) and relative risk (RR) (± standard error) for the neutered female and male being more likely to express the
condition (NA is not applicable)
Disease OR RR
Neutered female Neutered male Neutered female Neutered male
Atopic Dermatitis (ATOP) 2.24 ± 0.27* 1.51 ± 0.27* 2.21 ± 0.26* 1.50 ± 0.13*
Autoimmune Hemolytic Anemia (AIHA) 1.67 ± 0.28* 1.76 ± 0.31* 1.67 ± 0.28* 1.76 ± 0.31*
Canine Myasthenia Gravis (CMG) 1.19 ± 0.37 1.97 ± 1.01 1.19 ± 0.37 1.97 ± 1.01
Colitis (COL) 1.03 ± 0.11 0.98 ± 0.09 1.03 ± 0.11 0.98 ± 0.08
Hypoadrenocorticism (ADD) 1.49 ± 0.32* 2.07 ± 0.54* 1.49 ± 0.32* 2.07 ± 0.53*
Hypothyroidism (HYPO) 3.03 ± 0.39* 1.29 ± 0.11* 2.99 ± 0.39* 1.28 ± 0.10*
Immune-Mediated Polyarthritis (IMPA) 1.49 ± 0.37 1.02 ± 0.14 1.49 ± 0.37 1.02 ± 0.14
Immune-Mediated Thrombocytopenia (ITP) 3.14 ± 0.73* 2.05 ± 0.42* 3.13 ± 0.73* 2.05 ± 0.42*
Inflammatory Bowel Disease (IBD) 2.20 ± 0.54* 1.43 ± 0.23* 2.19 ± 0.54* 1.43 ± 0.23*
Lupus Erythematosus (LUP) 2.64 ± 1.24* 0.68 ± 0.16 2.64 ± 1.24* 0.68 ± 0.16
Pemphigus Complex (PEMC) 1.35 ± 0.39 1.64 ± 0.56 1.35 ± 0.39 1.64 ± 0.56
Pyometra (PYO) 0.04 ± 0.01* NA 0.04 ± 0.01* NA
Asterisks indicate a significant difference from the intact counterpart (p < 0.05)
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ADD, AIHA, ATOP, HYPO, IBD, and ITP. An increased
neutering risk for LUP was only observed for females. In
the conditions of ATOP, HYPO, IBD, and ITP in which
both neutered males and females exhibited greater risk of
disease, neutered females had an approximately 1.5 to 2
times higher risk than that for neutered males. Hypoadre-
nocorticism (ADD) showed a greater risk for neutered
males than neutered females. No conditions exhibited a
reduced risk with neutering except, as expected, pyometra
was significantly more likely to occur in intact females.
Discussion
The objective of this study was to determine if preva-
lence and risk of canine diseases associated with im-
mune function were affected by neutering. There have
been many reports on the benefits of neutering [18] and
although several studies have looked at the change in
prevalence of various conditions in relation to neuter
status [1, 15, 16, 45], there are few reports associating
neuter status with immune disorders [19, 21]. For several
diseases evaluated in the present study, neutered dogs
showed higher prevalence than their intact counterparts
and intact females had a reduced risk for most of the
diseases with the clear exception of pyometra, a dis-
order specifically chosen to have greater incidence in
intact females. For conditions other than pyometra,
neutering did not reduce the risk of immune disease.
Considering both female sex categories together, the
proportion of females diagnosed with these immune
conditions was slightly greater than when compared to
the aggregate male data. A 1999 review by Pedersen re-
ported the greatest prevalence of immune conditions
occurred in intact females and the lowest with intact
males [32] an assertion supported by the human litera-
ture [46] although those previous reports focused solely
on intact individuals. In the canine literature, diagnoses
of atopic dermatitis [47], CMG [20], IBD [48], lupus er-
ythematosus [49], and PEMC [50] do not exhibit sex
differences whereas for ADD, AIHA, IMPA, and ITP
females have approximately a twofold higher risk than
males [24, 51, 52]. A sex differential for those diseases did
not show significant differences in the present study
although there was a tendency of greater prevalence in
females for AIHA, ADD, and ITP but not at a twofold
higher risk as indicated in the literature possibly due to
the different populations assessed in each study.
Hoffman et al. noted that neutered dogs had longer
lifespans and were less vulnerable to death by infectious
disease than intact dogs [18]. The authors postulated
that gonadal steroid profiles [53] present in the intact
dog act as immune-suppressants making the intact dog
susceptible to infectious disease. Although gonadal ste-
roids are known to impact immune responsivity as noted
above, additional factors likely influence incidence and
severity of disease [54]. The present study evaluated con-
ditions that have a different etiology and progression
than pathogenic infectious diseases; it is reasonable that
the immune conditions evaluated in the present study
would respond differently to gonadal steroids. Further-
more the current study looked only at disease diagnosis
and expression but not mortality associated with disease.
Some conditions were diagnosed at earlier ages in the
intact dogs, more frequently for females than males.
Possible explanations for this observation include that
the health status of intact dogs may be more heavily
scrutinized prior to inclusion into breeding programs,
hormonal cyclicity related to gestation or the estrous
cycle [55], and an impact of a gravid uterus on expression
of immune conditions. Despite that for some conditions
intact females were diagnosed at earlier ages, intact fe-
males showed the lowest risk in many of the diseases
assessed, suggesting a health benefit for not neutering
female dogs. Females have higher immunoglobulin
levels (reviews include [23, 24]) partly due to increased
immunoglobulin production prompted by estrogen. In
mice, estrogen increases immunoglobulin production and
enhances antibody response, while testosterone inhibits
humoral immunity [26]. Perhaps this permits a stronger
humoral and cell-mediated immune response than seen in
males and a stronger response may benefit intact female
dogs by detecting threats more quickly and efficiently or
be better able to distinguish between self and non-self.
However, in previous studies of other species, intact
females also tend to be more prone to many auto-
immune diseases. In the present study, females had a
slight, though not significant, greater prevalence than males
for autoimmune conditions. An increased prevalence in
autoimmune diseases may reflect estrogens driving im-
munoglobulin production and/or permitting autoantibodies
to reach maturity whereas testosterone, through its inhibi-
tory action on immunoglobulin production, may prevent
autoantibody production.
One might predict that ablation of estrogens would re-
duce the risk for these conditions; that hypothesis was
not supported by the present data. Similarly, androgens
have been found to be immunosuppressors [56]; neutering
may release this inhibitory action and promote a more ac-
tive immune response. Further evaluation is needed to as-
sess whether a more robust immune response is a benefit
or detriment with respect to risk for autoimmune disorders
in the dog. Results from the present study, which did not
show intact females to be at greater risk for autoimmune
disorders, may be due to the particular autoimmune dis-
eases assessed, the methodology of experiments (e.g. retro-
spective or case study), species evaluated, or whether the
parameter of neuter status was included. Most studies that
have demonstrated a preponderance of female autoimmune
disease expression have focused upon intact animals.
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In the few studies evaluating gonadectomy, neutering
of male and female mice resulted in thymic and lymph-
oid tissue hyperplasia [57]. In normal development, the
thymus begins to involute following puberty as a conse-
quence of elevated gonadal steroids; the involution is
presumably responsible for the age associated decline in
immune function [58]. The withdrawal of the steroids by
gonadectomy may reverse the involution although older
animals may be less responsive [59]. Additionally, thymic
hyperplasia has been associated with autoimmune condi-
tions [60] suggesting gonadectomy may potentiate the
expression of immune-mediated diseases. Ovariectomy in
rats was shown to increase autoantibodies to thyroglobu-
lin [61] and, in agreement with the present data, a study
correlated neutering in dogs with hypothyroidism in both
sexes [62] which was speculated to have been associated
with autoantibody destruction of the thyroid gland al-
though autoantibody levels were not assessed. Further-
more, gonadectomy in both sexes of mice potentiates
Sjorgren’s syndrome, an autoimmune condition [63]. In
contrast, canine diabetes mellitus is associated with pan-
creatitis or autoimmune destruction of the pancreas [64]
and a study by Pöppl et al. demonstrated recovery from
the condition upon neutering [65]. Taken together these
findings suggest differential regulation of autoantibody
production in response to gonadal steroids; this view is
supported by human literature that both demonstrates
differences in tissue specific response to steroids for fe-
males and males as well as differences in expression of
autoimmune conditions [66].
In fact, for ADD, neutered males were at greater risk
than intact males and in females neutering only minimally
altered the risk of disease. The data indicate a protective
role for androgens in ADD, a view supported by an early
study of a female child with hypoadrenocorticism whose
condition improved with the administration of androgens
[67] and other human studies that indicate a correlation
between hypogonadism and severity of the hypoadreno-
cortical condition most particularly evident in males [68].
Additionally, studies using mice have shown that gonadec-
tomy affects the hypothalamic-pituitary-adrenal axis in
a sex-specific manner: neutered males produce larger
quantities of corticosterone from the adrenal [57]. That
alteration may account for the higher risk for hypoa-
drenocorticism observed in the neutered male dogs
along with a role for androgens in adrenal function.
The finding also illustrates that specific tissues respond
to the gonadal steroids differentially possibly accounting
for the sex specific risks seen for immune diseases with
neutering.
Lupus in mice has been found to be accelerated with
estrogen administration and blunted with androgen admin-
istration [23, 24]. Interestingly in mice prone to systemic
lupus erythematosus, neutering reduces mortality in female
mice yet guarantees mortality in males; treatment of intact
females with testosterone and dihydrotestosterone extends
their lifespan [69]. Although in the present study, the risk
of canine lupus erythematosus was higher in neutered fe-
males than either male category or intact females, caution
is needed in interpreting this risk because the prevalence of
lupus in intact females in the present study was very small
and other studies in multiple species, including dogs, show
a correlation between estrogen and increased morbidity of
lupus [69].
For conditions with an elevated risk associated with
neutering, the gonadal steroids may serve a protective
role. Diseases such as atopic dermatitis and IBD, where
the mechanism of disease onset involves inflammation,
higher concentrations of sex steroids present in intact
dogs may exert an anti-inflammatory effect to prevent
disease progression similar to what has been reported in
mice [70]. The anti-inflammatory effects of estradiol are
believed to be mediated by estrogen receptor blocking
intracellular trafficking of the p65 transcription factor,
that would normally be translocated to the nucleus to drive
transcription of proinflammatory proteins such as cytokines
and chemokines [71]. A similar anti-inflammatory effect
may occur in the dog. Additionally, estradiol has an antioxi-
dant effect in mice [70] and a recent study in dogs reported
that gonadectomized females have a greater risk for
oxidative stress [72] which may lead to greater susceptibil-
ity for immune diseases.
Canine atopic dermatitis is a complex disease influenced
by genetic predisposition and environmental factors.
Nearly half of the risk for atopy is attributed to the genetic
background of the dog, with as many as 54 different
genes exhibiting differential transcription in atopy cases
[73]. Environmental factors vary with atopy risk influ-
enced by geographic location, rainfall, proximity to other
animals, and rural versus urban habitat [73] though no
published studies assessed the influence of sex steroids on
atopy. It is a common disorder with estimates of up to
10% of dogs affected with both sexes equally impacted
[47] and even though the present study population preva-
lence was only ~1.8%, it was one of the most prevalent
diseases under study consistent with previous reports
of conditions that prompt veterinary visits [74]. The
lower prevalence may reflect the population under
study representing patients at a referral hospital with
only the most severe cases seen. Neutered females had
a much greater risk than the other sex categories indi-
cating a strong suppressive effect of estrogens on the
expression of the disease. Atopic dermatitis involves
the production of IgE or IgGd, a subset of IgG anti-
bodies, in response to antigens in the environment with
IgE being viewed as more diagnostic and implicated in
causality though there exists conflicting reports on the
latter [75–77].
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Differences in sensitization of a biological pathway in
erythrocytes, thrombocytes, or immune cells of the dog
by estrogen or progesterone in the female may play a
role in the hematologic diseases. AIHA and ITP involve
the destruction of erythrocytes and thrombocytes, compo-
nents of blood that have a high degree of regeneration. If
estrogen or progesterone control cell surface markers on
thrombocytes or erythrocytes, removal of estrogen or pro-
gesterone might change cell surface markers and cause
the thrombocytes or erythrocytes to be recognized as
non-self. A comparable hypothesis was proposed for
colon cancer in women where it was postulated that estro-
gen sensitized and inhibited colon cells from becoming
cancerous because following estrogen withdrawal, there
was an increase in risk for having tumors [78]. Similar hy-
potheses have also been postulated for hemangiosarcoma
and mast cell tumor development in the dog [1].
It is important to note that even though the study
population included more than 90,000 dogs and expres-
sion of the diseases were statistically prevalent, the actual
prevalence of the conditions studied was not high and the
prevalence of diagnosis declined over the 15 years evalu-
ated. Additionally, this was a retrospective study limited to
the dogs seen at a referral veterinary hospital and may not
reflect the prevalence of the population at large but rather
may be biased to complex or more severe cases. However,
the prevalence of disease seen in the present study does
concur with other studies of much larger numbers of
dogs, such as a study done using records from the Banfield
hospital population which found 1.7% of dogs were diag-
nosed with atopy out of a population of 1,345,697 dogs in
2007 [79], a similar prevalence to that seen with the
present study. Finally the study indicates a correlation of
neutering and disease status but because of the retrospect-
ive nature does not prove causality. This is especially true
given the known genetic contributions to some canine
autoimmune disorders [80]. Thus, although the current
results indicate a significant risk associated with neutering,
additional prospective studies are warranted to confirm
the relationship of sex steroids and autoimmune risk seen
in this study.
Conclusions
Neutering has tangible benefits such as eliminating un-
wanted reproduction in dogs [1, 81], lowering the inci-
dence of reproductive cancers, and increasing lifespan
[2, 18]. In contrast, neutered females may display in-
creased dominance aggression and urinary incontinence
[81–83] and susceptibility to certain neoplasias [14]. The
role of neutering on immune function must also be
taken into account. Six of the autoimmune diseases eval-
uated showed an increased prevalence in neutered dogs,
supporting the concept that neutering may have a detri-
mental effect on a canine’s health and immune function.
Lupus was the only disease that did not show increased
prevalence in neutered dogs of both sexes compared to
intact dogs. These findings indicate the importance of
sex steroids on immune function and suggest a role of
these hormones on self-recognition. Furthermore, the
data underscore the importance of dog owners engaging
in a thoughtful conversation with their veterinarian as to
the advantages and potential risks of neutering.
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